solver.press

Integrating multi-tissue transcriptomic signatures from Multiple Sclerosis studies with subgraph isomorphism algorithms will enable the identification of conserved molecular interaction motifs related to disease progression.

BiologyJun 8, 2026Evaluation Score: 63%

Adversarial Debate Score

62% survival rate under critique

Expert panel critique

Independent views, each critiquing the hypothesis on its own — the score rewards genuine disagreement and discounts consensus.

ChatGPT: The hypothesis is falsifiable and innovative, leveraging established computational methods (subgraph isomorphism) for a novel integrative application in MS. However, while cited works support the use of transcriptomics and graph-based analyses in disease contexts, none directly demonstrate this s...
Mistral: The hypothesis is falsifiable and aligns with current multi-omics and graph-based methods, but the supporting papers only indirectly address its key claims (e.g., subgraph isomorphism in MS), leaving counterarguments about generalizability and biological interpretability untested.
Gemini: The hypothesis is falsifiable and combines relevant techniques (transcriptomics
Grok: Hypothesis is plausible in principle (graph methods + transcriptomics exist separately) but poorly supported by the listed papers, which cover MS ML pipelines and drug synergy graphs without evidence for conserved motif detection or cross-tissue progression links; falsifiability is high but obvio...
Claude: The hypothesis is falsifiable and draws on genuine methodological components — multi-tissue MS transcriptomics is supported by the ML/transcriptomics paper, and graph isomorphism networks appear in the drug synergy paper — but the integration of these two strands is speculative and underspeci...

Supporting Research Papers

Computational Result

📖 Literature-assessed (LLM)· literature_meta

An LLM's reading of the literature — not computational verification.

Potential for motif discovery in MS using transcriptomic data.

Method: literature_meta · Result: inconclusive · Confidence: 60%

Formal Verification

Z3 logical consistency:✅ Consistent

Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.

Experimental Validation Package

This discovery has a Claude-generated validation package with a full experimental design.

Precise Hypothesis

Applying subgraph isomorphism (or approximate/relaxed subgraph-matching) algorithms to co-expression / protein-interaction networks derived from multiple independent MS transcriptomic datasets (blood, CSF, CNS lesion, CD8+ T-cell scRNA-seq) will recover a statistically enriched set of conserved multi-gene interaction motifs (3–6 node subgraphs) — anchored on DNMT1/TRIM28/SETDB1/EHMT2, ZNF740/BRD2/BRD3/BRD4, and CTSS/CSF1R/PTPRC/CD74 — that (a) occur at significantly higher frequency in disease-vs-control networks than in degree-preserving randomized null networks (permutation p<0.01, FDR<0.05), and (b) are reproducible across ≥2 independent GEO datasets (GSE193770, GSE108000, GSE138614) and the CELLxGENE Census cross-modal atlas, and (c) whose node membership correlates with the CA-RIM disease-progression composite score (Spearman ρ>0.5, p<0.05) more than degree/module-matched random subgraphs of equivalent size.

Disproof criteria:
  • Motif enrichment in disease networks is not significantly different from degree-preserving random graph nulls (permutation p≥0.01 after Bonferroni/FDR correction across all tested motif sizes).
  • Candidate motifs (DNMT1/TRIM28/SETDB1/EHMT2; ZNF740/BRD2-4; CTSS/CSF1R/PTPRC) fail to replicate in at least 2 of the 3 independent datasets (GSE193770, GSE108000, GSE138614).
  • Motif node composite scores show no significant correlation (ρ<0.3 or p≥0.05) with CA-RIM progression score.
  • Subgraph isomorphism results are unstable under bootstrap resampling of network edges (Jaccard similarity of top-20 motifs <0.4 across 100 bootstraps).
  • Motifs recovered are indistinguishable from generic high-degree-hub artifacts (i.e., disappear when hub nodes are removed/controlled for).

Spine & Adversarial Read

  • highWhy subgraph isomorphism specifically rather than simpler, already-validated network proximity scoring (which the source preprint already used in Phase 4) or established module-detection tools (MCODE, jActiveModules, WGCNA)? The EVP does not justify the incremental value of exact/relaxed subgraph matching over cheaper, more standard module-detection methods.
    Partial resolution: subgraph isomorphism targets specific recurring wiring patterns (motifs) rather than just densely-connected modules, which is a distinct and complementary question to proximity/module scoring — but this EVP does not include a head-to-head benchmark against MCODE/jActiveModules to demonstrate subgraph isomorphism adds information beyond what those cheaper methods would find. This is an acknowledged gap; a benchmarking sub-step should be added before claiming methodological necessity.
  • highThe composite score used to seed and annotate nodes already includes network-proximity-like disease_evidence weighting (20%), so any correlation between motif membership and CA-RIM progression score may be circular rather than independent validation.
    Acknowledged explicitly in KNOWN_FAILURE_MODES; a leave-one-feature-out ablation (re-running composite score without the disease_evidence/network term) is specified as a needed control but has not yet been executed — this remains an open methodological risk, not yet resolved.
  • mediumDNMT1 and ZNF740 signals are CD8+ T-cell-restricted per the source preprint's own limitation note; using bulk cohort GSE138614 for 'replication' of these two targets' motifs risks a false-negative interpretation being wrongly read as disproof.
    Resolved procedurally — protocol explicitly treats bulk-cohort null results for DNMT1/ZNF740 as inconclusive rather than disproof (see FAILURE_CRITERIA and KNOWN_FAILURE_MODES), and requires CELLxGENE Census cross-modal projection as the authoritative cell-type-resolved validation layer instead.

Experimental Protocol

Minimum viable test (MVT): Build 2 co-expression/PPI-integrated graphs (MS CA-RIM vs. control) from GSE193770 (CD8+ T-cell scRNA-seq, pseudobulked per cluster) and GSE138614 (bulk validation cohort), seed with the 50-gene MS STRING seed set plus the 5 named targets, run a relaxed subgraph isomorphism/motif search (e.g., gtrieScan, NetMatchStar, or graph neural network-based subgraph matching as a soft alternative) restricted to 3–6 node motifs, compare frequency against 1,000 degree-preserving randomized nulls (configuration model), and test replication in a third dataset (GSE108000) plus CELLxGENE Census cross-modal atlas as an orthogonal validation layer.

Required datasets:
  • GEO GSE193770 (CD8+ T-cell scRNA-seq, primary discovery)
  • GEO GSE108000 (independent MS cohort, replication)
  • GEO GSE138614 (bulk MS blood, replication — already shows CTSS/FGF2/SLCO2B1 signal)
  • CELLxGENE Census (cross-modal single-cell atlas for cell-type deconvolution)
  • GTEx v10 (tissue-specificity / druggability priors)
  • STRING v12 (physical + functional interaction network, confidence ≥0.4 and ≥0.7 sensitivity bands)
  • BioGRID (orthogonal PPI validation)
  • scVI atlas (gs://aegismind-tpu-results/ms_phase2/results/) — 36,966 cells × 13,807 genes, 30 Leiden clusters
  • 50-gene MS seed gene set (from source preprint, STAT3/IFNG/CSF1R/PTPRC-anchored)
  • Software: NetworkX/igraph, gtrieScan or NetMatchStar (exact subgraph isomorphism), optionally a GNN subgraph-matching baseline (e.g., NeuroMatch/GLASGOW solver), scVI/scANVI for pseudobulking, R/limma or DESeq2 for DEG re-derivation.
Success:
  • ≥3 motifs (3–6 nodes) enriched at FDR<0.05 vs. randomized nulls in ≥2/3 independent cohorts.
  • At least 1 motif each anchored on DNMT1, ZNF740, and CTSS achieving the above threshold.
  • Motif-membership composite score correlates with CA-RIM progression score at Spearman ρ>0.5, p<0.05.
  • Bootstrap stability: Jaccard similarity of top-20 motifs ≥0.5 across 100 resamples.
  • DNMT1/ZNF740 motifs confirmed CD8+ T-cell-restricted in CELLxGENE Census cross-modal check (≥70% of expressing cells in CD8+ compartment).
Failure:
  • No motif reaches FDR<0.05 enrichment in more than 1 of 3 cohorts.
  • Enriched motifs correlate with CA-RIM score at ρ<0.3 or fail significance.
  • Motifs collapse to generic hub artifacts (disappear after hub-node removal control).
  • Bootstrap Jaccard similarity <0.4 (unstable, non-reproducible motif calls).
  • DNMT1/ZNF740 signal shown to be an artifact of bulk-tissue dilution correction rather than genuine CD8+-restricted biology.

100

GPU hours

30d

Time to result

$1,000

Min cost

$10,000

Full cost

ROI Projection

Implementation Sketch

# Pseudocode
for cohort in [GSE193770_pseudobulk, GSE108000, GSE138614]:
    deg = run_deseq2(cohort, fdr_thresh=0.1)
    seed_genes = load_seed_set(50_gene_MS_seed) + [DNMT1, ZNF740, CTSS, FGF2, SLCO2B1, BRD2, BRD3, BRD4]
    nodes = deg.genes | seed_genes
    G_disease = build_string_graph(nodes, confidence=0.4)
    annotate_composite_score(G_disease, weights=[0.30,0.30,0.20,0.20])

    motifs_obs = subgraph_isomorphism_search(G_disease, size_range=(3,6), anchors=[DNMT1, ZNF740, CTSS])

    null_freqs = []
    for i in range(1000):
        G_null = configuration_model_rewire(G_disease, preserve_degree=True)
        null_freqs.append(subgraph_isomorphism_search(G_null, size_range=(3,6), anchors=same))

    pvals = empirical_pvalue(motifs_obs, null_freqs)
    fdr = benjamini_hochberg(pvals)
    results[cohort] = motifs_obs[fdr < 0.05]

replicated_motifs = intersect_across(results, min_cohorts=2)
corr = spearman(motif_membership_score, CA_RIM_progression_score)
stability = bootstrap_jaccard(G_disease, n=100, subsample=0.8)
celltype_check = project_onto_cellxgene_census(replicated_motifs, expect="CD8+ restricted for DNMT1/ZNF740")
Abort checkpoints:
  • After Step 7 (initial enrichment test in GSE193770 only): if zero motifs reach even nominal p<0.05 pre-FDR correction, abort before running full 3-cohort replication (saves ~60% of compute budget).
  • After Step 8 (cross-cohort replication check): if no motif replicates in ≥2/3 cohorts, abort before CA-RIM correlation and bootstrap stability steps.
  • After Step 10 (bootstrap stability): if Jaccard similarity <0.3, abort before CELLxGENE cross-modal validation (Step 11) since motifs are already non-reproducible.
  • Mid-pipeline compute checkpoint: if null-model generation (1,000 rewires × 3 cohorts) exceeds 40% of allocated CPU budget without completing, switch to reduced null count (n=200) with adjusted p-value resolution and flag as reduced-power result.

NAMED_EXPERTS: []

CLOSEST_EXISTING_WORK: []

NOVELTY_NARROWING_REQUIRED: false

SPINE_STATEMENT: This hypothesis tests whether relaxed subgraph isomorphism applied to multi-cohort MS transcriptomic interaction networks recovers statistically enriched, cross-dataset-reproducible gene motifs anchored on DNMT1, ZNF740, and CTSS that correlate with disease progression more strongly than random degree-matched subgraphs.

Source

AegisMind Research
Need AI to work rigorously on your problems? AegisMind uses the same multi-model engine for personal and professional use. Get started